Patient | Sex | Age | Initial reaction | S-IgE | ICT previously positive | ICT positive | Histamine in eluate | Challenge | Time interval (months) | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Culprit drug | Pen V | Pen G | AMP | AX | Symptoms | Drug | Initial reaction → microdialysis | First ICT → microdialysis | ||||||
1 | M | 64 | Ana | MC | < 0.35 | < 0.35 | < 0.35 | < 0.35 | MC | MC | + | ND (Ana) | − | 2 | 0.25 |
2 | F | 46 | Ana | Pen V | < 0.35 | < 0.35 | < 0.35 | < 0.35 | BP | BP | + | ND (Ana) | − | 6 | 4 |
3 | F | 46 | Urt | Pen V | 1.61 | 1.65 | 1.25 | < 0.35 | AMP, BP | AMP | − | ND (SRI) | − | 91 | 84 |
4 | M | 58 | Ana | DX | < 0.35 | < 0.35 | < 0.35 | < 0.35 | BP, DX, AMP, MC* | − | − | Positive (Urt) | DX | 27 | 26 |
5 | F | 60 | Urt + Ang | Pen V | < 0.35 | < 0.35 | < 0.35 | < 0.35 | BP, AMP* | − | − | Positive (Urt) | Pen V | 90 | 84 |
6 | F | 23 | Urt | Pen V | < 0.35 | < 0.35 | < 0.35 | < 0.35 | AX | − | − | Positive (Urt + Ang) | Pen V | 5 | 0.5 |
7 | F | 58 | Ana | Pen V | 2.85 | < 0.35 | < 0.35 | < 0.35 | BP* | − | − | Positive (Urt) | Pen V | 101 | 95 |
8 | F | 51 | Urt | Pen V | 2.43 | < 0.35 | < 0.35 | < 0.35 | BP, AMP, AX | BP, AMP, AX | − | Positive (Urt) | Pen V | 3 | 0.5 |
9 | F | 50 | Urt | AX + Cla | < 0.35 | < 0.35 | < 0.35 | < 0.35 | AX | AX | + | Positive (Urt) | AX + Cla | 11 | 1 |
10 | F | 50 | Urt | Pen V | < 0.35 | < 0.35 | < 0.35 | < 0.35 | BP | BP | + | Positive (Urt) | Pen V | 1 | 0.25 |
11 | F | 63 | Erythema | MC | < 0.35 | < 0.35 | < 0.35 | < 0.35 | MC | MC | − | ND (DPI) | − | 4 | 3 |
12 | F | 39 | Uns. rash | DX | < 0.35 | < 0.35 | < 0.35 | < 0.35 | DX | − | − | ND (DPI) | − | 17 | 4 |
13 | F | 70 | Uns. rash | Pen V | < 0.35 | < 0.35 | < 0.35 | < 0.35 | BP, MC | BP, AMP | − | ND (DPI) | − | 240 | 0.5 |
14 | F | 46 | Urt | Pen V | < 0.35 | < 0.35 | < 0.35 | < 0.35 | BP | − | − | Negative | Pen V | 29 | 24 |
15 | M | 54 | Urt | Pen V | < 0.35 | < 0.35 | < 0.35 | < 0.35 | BP | BP | − | Negative | Pen V | 18 | 6 |
16 | F | 58 | Urt | MC | < 0.35 | < 0.35 | 1.64 | 1.19 | BP, AMP, MC | − | − | Negative | MC + AMP | 7 | 5 |
17 | M | 42 | Uns. rash | AX | < 0.35 | < 0.35 | < 0.35 | < 0.35 | AX | − | − | Negative | AX | 12 | 0.25 |
18 | F | 46 | Urt | Pen V | < 0.35 | < 0.35 | < 0.35 | < 0.35 | AX | BP | − | Negative | Pen V | 9 | 1 |
19 | M | 48 | Ana | Pen V | 2.50 | < 0.35 | < 0.35 | < 0.35 | BP, AMP | − | − | ND (refused) | − | 40 | 39 |
20 | M | 55 | Ana | Pen V | < 0.35 | < 0.35 | < 0.35 | < 0.35 | BP* | − | − | ND (refused) | − | 82 | 79 |
21 | F | 45 | Urt | Pen V | < 0.35 | < 0.35 | < 0.35 | < 0.35 | BP, AMP | − | − | ND (refused) | − | 33 | 32 |